ANGELA ZIMMERMAN: Open Payments
NPI 1588815690 · GEORGETOWN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 52 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $469 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $320 |
| ABBVIE INC. | 11 | $216 |
| Corium, LLC | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| Bausch Health US, LLC | 3 | $57 |
| Alkermes, Inc. | 2 | $55 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: FANAPT, VRAYLAR, Azstarys, COBENFY, TRINTELLIX, Auvelity, APLENZIN, ARISTADA.
Industry payments across CO — which companies pay providers there.
